Association of Hepetitis B & C Virus infection in Non Hodgkin’s Lymphoma: A Case Control Study

Authors: Shaikh Khalid Muhammad, Bashir Ahmed Shaikh, Kouro Mal Gurbakhshani, Shafique Rehman Shah, Muhammad Aslam Soomro

CHANDKA MEDICAL COLLEGE & HOSPITAL LARKANA.

Volume 18 | Issue 1

Published: November 6, 2026

Abstract

To determine the association between hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and Non Hodgkin’s Lymphoma (NHL). Duration & Design: This 2 year observational and analytical, case control study was started on 1st January 2009 at C.M.C Larkana, after approval of ethical review committee. Methods & Materials: After informed written consent, blood samples from 361 NHL cases and 1444 age and sex matched controls (2 groups) meeting our selection criteria, were sent for detection of HBsAg and Anti-HCV Ab on 3rd generation ELISA. Pearson’s chi-square test was applied to compare HBsAg and Anti-HCV Ab seropositivity in cases and controls and odd ratios were computed using SPSS version 10. Results: 69 (19.1%) of cases, 55 (7.6%) controls in group 1(1st Degree Relatives) and 60 (8.3%) controls in group 2 (Non Hematological Malignancy) were HBsAg positive, with odd ratios of 2.86 (95% CI; 1.96 – 4.19) for control group 1 and 2.60 (95% CI; 1.79 – 3.78) for control group 2. Beside, 52 (14.4%) of cases, 53 (7.3%) subjects in control group 1and 58 (8.0%) in control group 2 were Anti-HCV Ab positive, with odd ratios of 2.12 (95% CI; 1.41 – 3.18) for control group 1 and 1.92 (95% CI; 1.29 – 2.86) for control group 2. P value was 0.000 for both. Conclusion: HBsAg and Anti-HCV Ab seropositivity is associated with 2-3 times risk of development of NHL.

Keywords: HBV, HBsAg, HCV, Anti-HCV Ab, ELISA, Association, NHL.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF